Fredric N. Eshelman, Director, 10% Owner at Furiex Pharmaceuticals, Inc. (FURX), bought 55,000 shares at $16.93 ($947K) on 2012-05-22, disclosed to the SEC on 2012-05-24.
Open-market purchase of $947k FURX by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.93 | 35,000 | $593K | 62.6% |
| 2 | $17.73 | 20,000 | $355K | 37.4% |
| Total | $17.22 avg | 55,000 | $947K | 100% |
| Filing → |
| LQDA | SELL | 2021-01-21 | $872K | — | Filing → |
| LQDA | SELL | 2021-01-19 | $81K | — | Filing → |
| LQDA | SELL | 2021-01-15 | $219K | — | Filing → |